CXCR4 and hepatocellular carcinoma: We previously showed that BM-MSCs potentiate osteosarcoma and hepatocellular carcinoma cells growth and migration and that treatment with CXCR4 antagonists, AMD3100 and Peptide R, reduced migration and invasion BM-MSCs mediated10.